GENVOYA
GENVOYA
Approved
DIN Number
02449498
Drug Class
Human
Market Date
Feb 3, 2016
Company
HC
gilead sciences canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02449498
AIG Number0457610001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR18 EMTRICITABINE, TENOFOVIR ALAFENAMIDE, ELVITEGRAVIR AND COBICISTAT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.12
Health Canada Classification
ACTIVE INGREDIENTS (4)
COBICISTATActive
Strength: 150 MG
Monograph: COBICISTAT
ELVITEGRAVIRActive
Strength: 150 MG
Monograph: ELVITEGRAVIR
EMTRICITABINEActive
Strength: 200 MG
Monograph: EMTRICITABINE
TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE)Active
Strength: 10 MG
Monograph: TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE)